New products constitute main impetus for pharmacy price growth

… According to PEX PharmaSequence, newly introduced products, in many cases, cost more than other items in the same categories previously available on the market. This means that new items constitute the main driver of price increases and this could lead to market growth.   

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.